Company Profile | February 27, 2014

2014 CRO Leadership Awards Winner

celerion applied translational medicine

Categories Won:

  1. Quality

  2. Reliability

  3. Regulatory

  4. Productivity

  5. Innovation

 

Drug Life Cycle Stages:
Research & Development: Clinical (Phase 1, Phase 2)
 

Main Service Areas:
Bioanalytical, Clinical

Services & Capabilities:
Celerion conducts first-in-human, clinical proof-of-concept, cardiac safety, and NDA -enabling clinical pharmacology studies. Support is also provided in statistics, and PK/PD analysis, small/large molecule
bioanalytical services, as well as program management.

Therapeutic Areas:
Provide support in metabolic diseases, respiratory, inflammation, cardiovascular, hypertension, ophthalmology, and infectious diseases.

Susan Thornton, PH.D.

president and CEO

“Celerion, a leader in early clinical research, delivers applied translational medicine through the implementation of innovative strategies to generate key data very early and enable faster go/no-go decisions in drug  development. For more than 40 years our experienced people, scientific
and operational excellence, combined with our innovative approach, have enabled us to deliver high-quality data while reducing timelines and
cost for our clients. It is an honor to have our clients recognize us with these awards.”